Single blind, multicentre, randomized, controlled trial testing the effects of a novel nutraceutical compound on plasma lipid and cardiovascular risk factors: Results of the interim analysis

The clustering of high levels of LDL cholesterol (LDL-C) and other risk factors represents a predisposing condition for atherosclerotic disease development. Cardiovascular prevention is based on effective control of these conditions. In adult subjects with mild hypercholesterolemia we compared in th...

Ausführliche Beschreibung

Gespeichert in:

Bibliographische Detailangaben
Veröffentlicht in:	Nutrition, metabolism, and cardiovascular diseases metabolism, and cardiovascular diseases, 2017-10, Vol.27 (10), p.850-857
Hauptverfasser:	Trimarco, V., Battistoni, A., Tocci, G., Coluccia, R., Manzi, M.V., Izzo, R., Volpe, M.
Format:	Artikel
Sprache:	eng
Schlagworte:	Adult Aged Armolipid Plus Biomarkers - blood Blood Glucose - drug effects Blood Glucose - metabolism Blood Pressure - drug effects Cardiovascular Diseases - diagnosis Cardiovascular Diseases - etiology Cardiovascular Diseases - prevention & control Cardiovascular prevention Cholesterol, HDL - blood Cholesterol, LDL - blood Dietary Supplements - adverse effects Female Glycated Hemoglobin A - metabolism Humans Hypercholesterolemia Hypercholesterolemia - blood Hypercholesterolemia - complications Hypercholesterolemia - diagnosis Hypercholesterolemia - drug therapy Hypolipidemic Agents - adverse effects Hypolipidemic Agents - therapeutic use Insulin - blood Italy LopiGLIK Male Middle Aged Morus - chemistry Nutraceuticals Phytotherapy Plant Extracts - adverse effects Plant Extracts - isolation & purification Plant Extracts - therapeutic use Plants, Medicinal Risk Factors Single-Blind Method Time Factors Treatment Outcome
Online-Zugang:	Volltext
Tags:	Tag hinzufügen Keine Tags, Fügen Sie den ersten Tag hinzu!

Schreiben Sie den ersten Kommentar!